Abstract:This study aimed to identify the chromosomal anomalies and copy number variations (CNVs) in autism spectrum disorder (ASD) and to provide genotype/phenotype correlations. This shows aCGH images of patients with pathogenic or likely pathogenic changes: (a) 70 kb copy number loss in region 22q13.33; (b) 10.1 Mb copy number gain in region 15q13.2q13.3; (c) 6.3 Mb copy number gain in region 3p22.3p22.2; (d) 699 kb copy number gain in region 15q11.2q12; and (e) 500 kb copy number loss in region 15q11.2. This study aimed to identify the chromosomal anomalies and copy number variations (CNVs) in autism spectrum disorder (ASD) and to provide genotype/phenotype correlations. Fifty‐four patients diagnosed with ASD between March 2021 and June 2022 were included in the study. Patients were evaluated by cytogenetic analysis and array comparative genomic hybridisation analysis (aCGH). The structural and numerical chromosomal anomaly was detected in 3.7%, and the CNVs were identified in 18.52% of patients. Of the CNVs detected, 27.3% were identified as pathogenic, 18.2% as likely pathogenic and 54.5% as VUS. The copy number gain rate of the detected CNVs was higher than the copy number losses rate, 70% and 30% respectively. As an important finding in the study, a new pathogenic CNV with a 6.3‐mb copy number gain in the 3p22.3p22.2 region, whose gene region had not been previously defined in OMIM, was detected. Identifying a genetic aetiology may provide clinicians with more information about disease prognosis and risk of recurrence.

Investigation of chromosomal anomalies and copy number variations in children diagnosed with autism spectrum disorder by array CGH method